Top

Supportive Care in Cancer

Published in:

01-05-2016 | Original Article

Unmet needs mediate the relationship between symptoms and quality of life in breast cancer survivors

Authors: K. K. F. Cheng, W. H. Wong, C. Koh

Published in: Supportive Care in Cancer | Issue 5/2016

Abstract

Purpose

This study aimed to compare the symptoms, unmet needs, and QoL reported by women at 6 months to <2 years and 2 to 5 years following surgery and adjuvant treatment for breast cancer. It also evaluated the relationships among symptoms, unmet needs, and QoL using structural equation modeling.

Methods

In this study, 113 and 137 survivors following breast cancer treatment 6 months to <2 years and 2 to 5 years, respectively, completed the Memorial Symptom Assessment Scale, the Supportive Care Needs Survey-34, and the Medical Outcomes Study 12-item Short Form Health Survey version 2.0 during their medical follow-up.

Results

The mean numbers of symptoms and unmet needs were 5.43 and 3.0, respectively, for survivors at <2 years, and 5.24 and 2.42, respectively, for survivors at 2 to 5 years following treatment. The most common reported symptoms were related primarily to physical domains. No significant differences were found between the two survivor groups on the MSAS scores. Survivors at <2 years reported significantly higher scores in Psychological and Health Care System/Information needs (p < 0.01), and lower composite scores in physical and mental QoL (p < 0.05) than those at 2 to 5 years post-treatment. Significant direct and indirect effects were found of symptom burden through unmet needs on survivors’ physical and mental QoL after adjustment for survival time, and the models showed a good fit.

Conclusions

Results suggest that breast cancer survivors continue to endure many symptoms independent of the survivorship period. The unmet needs mediate the relationship between symptom burden and survivors’ QoL.

Siegel R, DeSantis C, Virgo K, Stein K, Mariotto A, Smith T, Cooper D, Gansler T, Lerro C, Fedewa S, Lin C, Leach C, Cannady RS, Cho H, Scoppa S, Hachey M, Kirch R, Jemal A, Ward E (2012) Cancer treatment and survivorship statistics. CA Cancer J Clin 62(4):220–241CrossRefPubMed

Hodgkinson K, Butow P, Hunt GE, Pendlebury S, Hobbs KM, Wain G (2007) Breast cancer survivors’ supportive care needs 2–10 years after diagnosis. Support Care Cancer 15(5):515–523CrossRefPubMed

Mullan F (1985) Seasons of survival: reflections of a physician with cancer. N Engl J Med 313(4):270–273CrossRefPubMed

Gosain R, Miller K (2013) Symptoms and symptom management in long-term cancer survivors. Cancer J 19(5):405–409CrossRefPubMed

Bower JE (2008) Behavioral symptoms in patients with breast cancer and survivors. J Clin Oncol 26(5):768–767CrossRefPubMedPubMedCentral

Cleeland CS (2007) Symptom burden: multiple symptoms and their impact as patient-reported outcomes. J Natl Cancer Inst Monogr 37:16–21CrossRef

Janz NK, Mujahid M, Chung LK, Lantz PM, Hawley ST, Morrow M, Schwartz K, Katz SJ (2007) Symptom experience and quality of life of women following breast cancer treatment. J Women’s Health 16(9):1348–1361CrossRef

Fu OS, Crew KD, Jacobson JS, Greenlee H, Yu G, Campbell J, Ortiz Y, Hershman DL (2009) Ethnicity and persistent symptom burden in breast cancer survivors. J Cancer Surviv 3(4):241–250CrossRefPubMedPubMedCentral

Binkley JM, Harris SR, Levangie PK, Pearl M, Guglielmino J, Kraus V, Rowden D (2012) Patient perspectives on breast cancer treatment side effects and the prospective surveillance model for physical rehabilitation for women with breast cancer. Cancer 118(8 Suppl):2207–2216CrossRefPubMed

10.

Costanzo ES, Lutgendorf SK, Mattes ML, Robinson CB, Tewfik F, Roman SL (2007) Adjusting to life after treatment: distress and quality of life following treatment for breast cancer. Br J Cancer 97:1625–1631CrossRefPubMedPubMedCentral

11.

Eckhoff L, Knoop AS, Jensen MB, Ewertz M (2014) Persistence of docetaxel-induced neuropathy and impact on quality of life among breast cancer survivors. Eur J Cancer 51(3):292–300CrossRefPubMed

12.

Ganz PA, Kwan L, Stanton AL, Krupnick JL, Rowland JH, Meyerowitz BE (2004) Quality of life at the end of primary treatment of breast cancer: first results from the moving beyond cancer randomized trial. J Natl Cancer Inst Monogr 96(5):376–387CrossRef

13.

Kim SH, Lee R, Lee KS (2012) Symptoms and uncertainty in breast cancer survivors in Korea: differences by treatment trajectory. J Clin Nurs 21(7–8):1014–1023CrossRefPubMed

14.

Cheng KK, Darshini Devi R, Wong WH, Koh C (2014) Perceived symptoms and the supportive care needs of breast cancer survivors six months to five years post-treatment period. Eur J Oncol Nurs 18:3–9CrossRefPubMed

15.

Portenoy RK, Thaler HT, Kornblith AB, Lepore JM, Friedlander-Klar H, Kiyasu E (1994) The Memorial Symptom Assessment Scale: an instrument for the evaluation of symptom prevalence, characteristics and distress. Eur J Cancer 30A(9):1326–1336CrossRefPubMed

16.

Boyes A, Girgis A, Lecathelinais C (2009) Brief assessment of adult cancer patients’ perceived needs: development and validation of the 34-item Supportive Care Needs Survey (SCNS-SF34). J Eval Clin Pract 15(4):602–606CrossRefPubMed

17.

Ware JE, Kosinski M, Turner-Bowker DM, Gandek B (2005) How to score version 2 of the SF-12 health survey. QualityMetric Inc., Lincoln

18.

Saris-Baglama RN, Dewy CJ, Chisholm GB, Plumb E, King J, Rasicot P, Kosinski M, Bjorner JB, Ware JW (2010) QualityMetric Health Outcomes™ Scoring Software 4.0 user’s guide. QualityMetric Inc, Lincoln

19.

Sow WT, Wee HL, Wu Y, Tai ES, Gandek B, Lee J, Ma S, Heng D, Thumboo J (2014) Normative data for the Singapore English and Chinese SF-36 version 2 Health Survey. Ann Acad Med Singap 43:15–23PubMed

20.

Hoyle RH (1995) Structural equation modelling: concepts, issues and application. Sage Publications, Thousand Oaks

21.

Pachman DR, Barton DL, Swetz KM, Loprinzi CL (2012) Troublesome symptoms in cancer survivors: fatigue, insomnia, neuropathy, and pain. J Clin Oncol 30(30):3687–3696CrossRefPubMed

22.

Ganz PA, Kwan L, Stanton AL, Bower JE, Belin TR (2011) Physical and psychosocial recovery in the year after primary treatment of breast cancer. J Clin Oncol 29(9):1101–1109CrossRefPubMedPubMedCentral

23.

Ganz PA, Kwan L, Stanton AL, Bower JE, Belin TR (2000) Fatigue in breast cancer survivors: occurrence, correlates, and impact of quality of life. J Clin Oncol 18(4):743–753CrossRefPubMed

24.

Stone P, Richardson A, Ream E, Smith AG, Kerr DJ, Kearney N (2000) Cancer-related fatigue: inevitable, unimportant and untreatable? Results of a multi-centre patient survey. Ann Oncol 11(8):971–975CrossRefPubMed

25.

Kim Y, Hickok JT, Morrow G (2006) Fatigue and depression in cancer patients undergoing chemotherapy: an emotion approach. J Pain Symptom Manag 32(4):311–321CrossRef

26.

Berger AM, Gerber LH, Mayer DK (2012) Cancer-related fatigue. Cancer 118(Suppl 8):2261–2269CrossRefPubMed

27.

Girgis A, Boyes A, Sanson-Fisher RW, Burrows S (2000) Perceived needs of women diagnosed with breast cancer: rural versus urban location. Aust N Z J Public Health 24(2):166–173CrossRefPubMed

28.

Armes J, Crowe M, Colbourne L, Morgan H, Murrells T, Oakley C, Palmer N, Ream E, Young A, Richardson A (2009) Patients’ supportive care needs beyond the end of cancer treatment: a prospective longitudinal survey. J Clin Oncol 27(36):6172–6179CrossRefPubMed

29.

Thewes B, Butow P, Girgis A, Pendlebury S (2004) The psychosocial needs of breast cancer survivors: a qualitative study of the shared and unique needs of younger versus older survivors. Psycho-Oncology 13(3):177–189CrossRefPubMed

30.

Yoon J, Malin JL, Tisnado DM, Tao ML, Adams JL, Timmer MJ, Ganz PA, Kahn KL (2008) Symptom management after breast cancer treatment: is it influenced by patient characteristics? Breast Cancer Res Treat 108(1):69–77CrossRefPubMed

31.

Schmid-Buchi S, Halfens RJ, Dassen T, van den Borne B (2011) Psychosocial problems and needs of posttreatment patients with breast cancer and their relatives. Eur J Oncol Nurs 15(3):260–266CrossRefPubMed

32.

Philips KM, McGinty HL, Gonzalez BD, Jim HSL, Small BJ, Minton S, Andrykowski MA, Jacobsen PB (2013) Factors associated with breast cancer worry 3 years after completion of adjuvant treatment. Psycho-Oncology 22(4):936–939CrossRef

33.

Dunn LB, Langford DJ, Paul SM, Berman MB, Shumay DM, Kober K, Merriman JD, West C, Neuhaus JM, Miaskowski C (2014) Trajectories of fear of recurrence in women with breast cancer. Support Care Cancer. doi:10.1007/s00520-014-2513-8

34.

Sanson-Fisher R, Girgis A, Boyes A, Bonevski B, Burton L, Cook P (2000) The unmet supportive care needs of patients with cancer. Cancer 88(1):226–237CrossRefPubMed

35.

Gray RE, Fitch M, Greenberg M, Hampson A, Doherty M, Labrecque M (1998) The information needs of well, longer-term survivors of breast cancer. Patient Educ Couns 33(3):245–255CrossRefPubMed

36.

Yeom H, Heidrich SM (2009) Effect of perceived barriers to symptom management on quality of life in older breast cancer survivors. Cancer Nurs 23(4):309–316CrossRef

37.

So WKW, Chow KM, Chan HYL, Choi KC, Wan RWM, Mak SSS, Chair SY, Chan CWH (2014) Quality of life and most prevalent unmet needs of Chinese breast cancer survivors at one year after cancer treatment. Eur J Oncol Nurs 18:323–328CrossRefPubMed

38.

Akechi T, Okuyama T, Endo C, Sagawa R, Uchida M, Nakaguchi T, Akazawa T, Yamashita H, Toyama T, Furukawa TA (2011) Patient’s perceived need and psychological distress and/or quality of life in ambulatory breast cancer patients in Japan. Psycho-Oncology 20:497–505CrossRefPubMed

Title: Unmet needs mediate the relationship between symptoms and quality of life in breast cancer survivors
Authors: K. K. F. Cheng
W. H. Wong
C. Koh
Publication date: 01-05-2016
Publisher: Springer Berlin Heidelberg
Published in: Supportive Care in Cancer / Issue 5/2016
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI: https://doi.org/10.1007/s00520-015-2994-0

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 5/2016

End-of-life decision-making of terminally ill cancer patients in a tertiary cancer center in Shanghai, China

Characteristics and outcomes of patients with advanced cancer evaluated by a palliative care team at an emergency center. A retrospective study

Quality of life and symptom burden in patients with breast cancer treated with mastectomy and lumpectomy

Effects of a physical therapy program combined with manual lymphatic drainage on shoulder function, quality of life, lymphedema incidence, and pain in breast cancer patients with axillary web syndrome following axillary dissection

Family caregiving challenges in advanced colorectal cancer: patient and caregiver perspectives

Identifying functional impairment and rehabilitation needs in patients newly diagnosed with inoperable lung cancer: a structured literature review

Keynote webinar | Spotlight on antibody–drug conjugates in cancer